Cargando…

Subcutaneously Insertable Cardiac Monitor for Atrial Fibrillation and HF Using ECG and Phonocardiography as Biomarkers

Detalles Bibliográficos
Autor principal:	Bang, Jaeson
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Focus Issue: Technology and Heart Failure Therapeutics 2023 Shark Tank
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10149642/ https://www.ncbi.nlm.nih.gov/pubmed/37138813 http://dx.doi.org/10.1016/j.jacbts.2023.03.001

Ejemplares similares

A Subcutaneous Multiparameter Sensor With Integrated Interstitial Fluid Pressure Measurement for Remote Heart Failure Monitoring
por: Rothman, Alexander M.K., et al.
Publicado: (2023)

A Novel Multisensor Device for Absolute Intracardiac Pressure Measurement, Detection, and Management of Heart Failure
por: Mace, Matthew Ian
Publicado: (2023)

Minimally Invasive Fully Implantable Cardiac Support System to Restore Left Ventricular Function in Heart Failure
por: Schnegelsberg, Patrick N.J., et al.
Publicado: (2023)

Prolonged Low-Intensity Ultrasound Delivery as Potential Kidneys Treatment for Acutely Decompensated Heart Failure Patients
por: Rousso, Benny, et al.
Publicado: (2023)

Shark Attack: Introducing the 2023 Technology and Heart Failure Therapeutics Shark Tank Edition of JACC: Basic to Translational Science
por: Mann, Douglas L.
Publicado: (2023)

Highlights of Innovation and Technologies and Heart Failure Therapeutics: THT 2023
por: Burkhoff, Daniel
Publicado: (2023)

Novel Intranasal Loop Diuretic
por: Esque, Benjamin, et al.
Publicado: (2023)

Making Science Fun Again: Technology and Heart Failure Therapeutics 2022 Shark Tank
por: Mann, Douglas L.
Publicado: (2022)

Novel Noninvasive Biosensors and Artificial Intelligence for Optimized Heart Failure Management
por: Neill, Luke, et al.
Publicado: (2022)

Cardiac Pulmonary Nerve Stimulation (CPNS(TM)): A Novel Treatment for Acute Decompensated Heart Failure
por: Goedeke, Steve, et al.
Publicado: (2022)

Technology and Heart Failure Therapeutics (THT2022): A Glimpse Into the Future of Devices and Novel Therapies for Heart Failure
por: Burkhoff, Daniel, et al.
Publicado: (2022)

Highlighting the Unique Challenges Presented by Device Trials in Heart Failure
por: Mann, Douglas L.
Publicado: (2022)

Audicor Remote Patient Monitoring: FDA Breakthrough Device and Technology for Heart Failure Management
por: Fudim, Marat, et al.
Publicado: (2022)

Splanchnic Nerve Ablation for Volume Management in Heart Failure
por: Fudim, Marat, et al.
Publicado: (2022)

Wireless Powered and Water-Proof Mechanical Circulatory Support Device for Ambulatory Class III Heart Failure
por: Miller, Leslie, et al.
Publicado: (2022)

Synchronized Diaphragmatic Stimulation for the Treatment of Symptomatic Heart Failure: A Novel Implantable Therapy Concept
por: Fudim, Marat, et al.
Publicado: (2022)

Novel IVC Doraya Catheter Provides Congestion Relief in Patients With Acute Heart Failure
por: Zymliński, Robert, et al.
Publicado: (2022)

Does lateral approach preserve the right ventricular function after HeartMate 3 insertion?
por: Hayashi, Hideyuki, et al.
Publicado: (2023)

Improving the diagnosis of heart failure in patients with atrial fibrillation
por: Bunting, Karina V, et al.
Publicado: (2021)

Fibroelastic Tissue Ring Causing ECMO Catheter Obstruction: An Unusual Complication of Avalon Elite Catheter Insertion
por: Zhang, James Z., et al.
Publicado: (2021)

Catheter ablation and mortality, stroke and heart failure readmission with atrial fibrillation
por: Pallisgaard, Jannik Langtved, et al.
Publicado: (2020)

Guideline-directed therapy at discharge in patients with heart failure and atrial fibrillation
por: Ahn, Min-Soo, et al.
Publicado: (2020)

Clinical, ECG and echocardiographic clues to the diagnosis of TTR-related cardiomyopathy
por: Damy, Thibaud, et al.
Publicado: (2016)

Clinical disease presentation and ECG characteristics of LMNA mutation carriers
por: Ollila, Laura, et al.
Publicado: (2017)

Concomitant left atrial appendage closure during left ventricular assist device surgery can reduce ischaemic cerebrovascular accidents
por: Nishida, Hidefumi, et al.
Publicado: (2023)

Impact of atrial fibrillation in patients with heart failure and reduced, mid-range or preserved ejection fraction
por: Son, Mi Kyoung, et al.
Publicado: (2020)

Association of time‐to‐intravenous furosemide with mortality in acute heart failure: data from REPORT‐HF
por: Ouwerkerk, Wouter, et al.
Publicado: (2022)

ECG characteristics according to the presence of late gadolinium enhancement on cardiac MRI in hypertrophic cardiomyopathy
por: Grall, Sylvain, et al.
Publicado: (2014)

Relationships among achieved heart rate, β-blocker dose and long-term outcomes in patients with heart failure with atrial fibrillation
por: Miller, Robert J H, et al.
Publicado: (2016)

Outcomes of cardiac resynchronisation therapy in patients with heart failure with atrial fibrillation: a systematic review and meta-analysis of observational studies
por: Mustafa, Usman, et al.
Publicado: (2019)

Novel tech throws knock-out punch to ECG improving GP referral decisions to cardiology
por: Calcagno, Simone, et al.
Publicado: (2022)

Characterisation of circulating biomarkers before and after cardiac resynchronisation therapy and their role in predicting CRT response: the COVERT-HF study
por: McAloon, Christopher J, et al.
Publicado: (2018)

Rationale and design of the preserved versus reduced ejection fraction biomarker registry and precision medicine database for ambulatory patients with heart failure (PREFER-HF) study
por: Abboud, Andrew, et al.
Publicado: (2021)

Mechanical dyssynchrony is additive to ECG criteria and independently associated with reverse remodelling and clinical response to cardiac resynchronisation therapy in patients with advanced heart failure
por: Bank, Alan J, et al.
Publicado: (2015)

Rationale and design of the NEO-NORMAL-AF study examination of the usefulness of implantable loop recorder for arrhythmia detection including atrial fibrillation in heart failure with non-reduced ejection fraction cases: a pilot study
por: Sugiura, Junichi, et al.
Publicado: (2023)

Kolkata-Coventry comparative registry study of acute heart failure: an insight into the impact of public, private and universal health systems on patient outcomes in low–middle income cities (KOLCOV HF Study)
por: Banerjee, Suvro, et al.
Publicado: (2022)

Prevalence of left ventricular dysfunction in a UK community sample of very old people: the Newcastle 85+ study
por: Yousaf, Fahad, et al.
Publicado: (2012)

Effect of Left Ventricular Assist Device Implantation and Heart Transplantation on Habitual Physical Activity and Quality of Life()
por: Jakovljevic, Djordje G., et al.
Publicado: (2014)

The cost effectiveness of ivabradine in the treatment of chronic heart failure from the UK National Health Service perspective
por: Griffiths, A, et al.
Publicado: (2014)

Referral for Specialist Follow-up and Its Association With Post-discharge Mortality Among Patients With Systolic Heart Failure (from the National Heart Failure Audit for England and Wales)
por: Emdin, Connor A., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ikmrqf6cn2kem91gm317jdopmq